Endurant Capital Management as of March 31, 2019
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 69 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 5.5 | $14M | 291k | 47.71 | |
IntriCon Corporation | 5.5 | $14M | 553k | 25.08 | |
Icon (ICLR) | 5.5 | $14M | 101k | 136.58 | |
Vocera Communications | 4.9 | $12M | 391k | 31.63 | |
Cigna Corp (CI) | 4.3 | $11M | 67k | 160.81 | |
Spdr S&p 500 Etf (SPY) | 4.1 | $11M | 37k | 282.48 | |
Gilead Sciences (GILD) | 4.0 | $10M | 156k | 65.01 | |
Zimmer Holdings (ZBH) | 3.9 | $9.9M | 77k | 127.69 | |
Takeda Pharmaceutical (TAK) | 3.5 | $8.9M | 437k | 20.37 | |
Fluidigm Corporation convertible cor | 3.2 | $8.2M | 8.8M | 0.94 | |
Hca Holdings (HCA) | 3.1 | $7.8M | 60k | 130.39 | |
Wright Medical Group Nv | 3.1 | $7.8M | 247k | 31.45 | |
R1 Rcm | 2.9 | $7.3M | 750k | 9.67 | |
AtriCure (ATRC) | 2.8 | $7.1M | 267k | 26.79 | |
AmerisourceBergen (COR) | 2.8 | $7.0M | 89k | 79.52 | |
Laboratory Corp. of America Holdings | 2.7 | $6.9M | 45k | 152.98 | |
Avedro | 2.1 | $5.4M | 442k | 12.27 | |
Evolent Health (EVH) | 2.1 | $5.3M | 419k | 12.58 | |
Livanova Plc Ord (LIVN) | 1.6 | $4.1M | 42k | 97.25 | |
Irhythm Technologies (IRTC) | 1.5 | $3.8M | 50k | 74.96 | |
Health Care SPDR (XLV) | 1.5 | $3.7M | 41k | 91.74 | |
Tenet Healthcare Corporation (THC) | 1.4 | $3.5M | 122k | 28.84 | |
Aclaris Therapeutics (ACRS) | 1.3 | $3.3M | 546k | 5.99 | |
Medtronic (MDT) | 1.3 | $3.2M | 36k | 91.09 | |
Invesco Qqq Trust Series 1 (QQQ) | 1.2 | $3.0M | 17k | 179.64 | |
Centene Corporation (CNC) | 1.1 | $2.9M | 55k | 53.10 | |
Thermo Fisher Scientific (TMO) | 1.1 | $2.9M | 11k | 273.71 | |
Ocular Therapeutix (OCUL) | 1.1 | $2.8M | 716k | 3.97 | |
Luminex Corporation | 1.1 | $2.8M | 121k | 23.01 | |
Neon Therapeutics | 1.1 | $2.7M | 425k | 6.46 | |
Allergan | 1.1 | $2.7M | 18k | 146.42 | |
Liquidia Technologies (LQDA) | 1.1 | $2.7M | 235k | 11.38 | |
Anthem (ELV) | 1.0 | $2.6M | 9.1k | 286.99 | |
Bausch Health Companies (BHC) | 1.0 | $2.6M | 104k | 24.70 | |
Vericel (VCEL) | 0.8 | $2.2M | 123k | 17.51 | |
Intersect Ent | 0.8 | $2.1M | 66k | 32.16 | |
Krystal Biotech (KRYS) | 0.8 | $2.0M | 61k | 32.90 | |
Abbott Laboratories (ABT) | 0.8 | $1.9M | 24k | 79.95 | |
Axovant Sciences | 0.8 | $1.9M | 1.5M | 1.33 | |
Align Technology (ALGN) | 0.7 | $1.9M | 6.6k | 284.28 | |
Marinus Pharmaceuticals | 0.7 | $1.8M | 437k | 4.18 | |
Oxford Immunotec Global | 0.7 | $1.8M | 103k | 17.23 | |
Viking Therapeutics (VKTX) | 0.7 | $1.8M | 178k | 9.94 | |
Abbvie (ABBV) | 0.7 | $1.7M | 22k | 80.60 | |
Sarepta Therapeutics (SRPT) | 0.7 | $1.7M | 14k | 119.19 | |
Dentsply Sirona (XRAY) | 0.6 | $1.4M | 29k | 49.61 | |
Tivity Health | 0.5 | $1.4M | 78k | 17.55 | |
Senseonics Hldgs Inc note 5.250% 2/0 | 0.4 | $1.1M | 1.0M | 1.06 | |
Agilent Technologies Inc C ommon (A) | 0.4 | $1.0M | 13k | 80.35 | |
Osmotica Pharmaceuticals (RVLPQ) | 0.4 | $1.0M | 280k | 3.60 | |
Molina Healthcare (MOH) | 0.3 | $828k | 5.8k | 142.02 | |
Sientra | 0.3 | $758k | 88k | 8.58 | |
ImmunoGen | 0.3 | $735k | 271k | 2.71 | |
Teladoc (TDOC) | 0.3 | $731k | 13k | 55.58 | |
Axsome Therapeutics (AXSM) | 0.3 | $744k | 52k | 14.23 | |
Viewray (VRAYQ) | 0.3 | $714k | 97k | 7.39 | |
Henry Schein (HSIC) | 0.2 | $631k | 11k | 60.08 | |
Ptc Therapeutics I (PTCT) | 0.2 | $636k | 17k | 37.63 | |
CVS Caremark Corporation (CVS) | 0.2 | $595k | 11k | 53.91 | |
Haemonetics Corporation (HAE) | 0.2 | $585k | 6.7k | 87.43 | |
Vistagen Therapeutics | 0.2 | $462k | 361k | 1.28 | |
Anaptysbio Inc Common (ANAB) | 0.2 | $444k | 6.1k | 73.00 | |
Surgery Partners (SGRY) | 0.2 | $438k | 39k | 11.29 | |
Array BioPharma | 0.2 | $401k | 16k | 24.38 | |
Biohaven Pharmaceutical Holding | 0.1 | $385k | 7.5k | 51.48 | |
Dynavax Technologies (DVAX) | 0.1 | $302k | 41k | 7.31 | |
Gritstone Oncology Ord (GRTSQ) | 0.1 | $283k | 21k | 13.31 | |
Aldeyra Therapeutics (ALDX) | 0.1 | $213k | 24k | 9.03 | |
Proteostasis Therapeutics In | 0.1 | $165k | 131k | 1.26 |